Natural products and privileged structures

$93,897P50FY2005GMNIH

University Of Kansas Lawrence, Lawrence KS

Investigators

Linked publications & trials

Paper 35648806 Paper 35044775 Paper 33728787 Paper 32975949 Paper 31784317 Paper 31655253 Paper 31105961 Paper 30328426 Paper 30141903 Paper 28737400 Paper 28437113 Paper 27680534 Paper 27300761 Paper 27300570 Paper 27144688 Paper 26516291 Paper 26446396 Paper 26430955 Paper 26371961 Paper 26126123 Paper 25278636 Paper 25278635 Paper 25238555 Paper 24692693 Paper 24632658 Paper 24451589 Paper 24436496 Paper 24412067 Paper 24385680 Paper 24385679 Paper 24371362 Paper 24313225 Paper 24244871 Paper 24244052 Paper 24079459 Paper 23928050 Paper 23782037 Paper 23758452 Paper 23682712 Paper 23520410 Paper 23519554 Paper 23514214 Paper 23510238 Paper 23504237 Paper 23472819 Paper 23214463 Paper 23206164 Paper 23155229 Paper 23110553 Paper 23019462 Paper 23013049 Paper 22853708 Paper 22832549 Paper 22742883 Paper 22612549 Paper 22467977 Paper 22384820 Paper 22356459 Paper 22337070 Paper 22329405 Paper 22311745 Paper 22308111 Paper 22225535 Paper 22116791 Paper 22027744 Paper 22007996 Paper 21970468 Paper 21927510 Paper 21902243 Paper 21899284 Paper 21866904 Paper 21796690 Paper 21744843 Paper 21727956 Paper 21721520 Paper 21668016 Paper 21568288 Paper 21528920 Paper 21517105 Paper 21491889 Paper 21434675 Paper 21434604 Paper 21417435 Paper 21410207 Paper 21387477 Paper 21368188 Paper 21309582 Paper 21235252 Paper 21128690 Paper 21121636 Paper 21113432 Paper 21057590 Paper 21057588 Paper 20936802 Paper 20931578 Paper 20929269 Paper 20879738 Paper 20877442 Paper 20729985 Paper 20715214

Abstract

The main objective of this project is the synthesis of compound libraries based on enantiomerically pure, stereochemically well-defined, novel, versatile, and interesting molecular scaffolds that are derived from or inspired by natural products and privileged structures. The specific aims of this project are: 1. Prepare a demonstration library based on the eight-membered lactone natural product and powerful antitumor agent octalactin A via ring-closing metathesis (RCM) chemistry and evaluate the analogues for cytotoxic activity against human cancer cell lines. 2. Develop a new class of ionic norbornenyl linkers for combinatorial chemistry. 3. Preparation of trienomycin A analogues by combinatorial methods using both solid- and solution-phase technologies. 4. Utilization of polymer-supported phosphonium salts, olefin cross-metathesis, oligomeric chiral auxiliaries and PEG-supported dioxolanes during the construction of the macrocyclic core of trienomycin A. 5. Development of novel chemistry to prepare unique nitrogen-containing scaffolds. 6. Development of novel traceless linker methodology for solid phase asymmetric synthesis.

View original record on NIH RePORTER →